review Open AccessTop 1% cited

AME Position Statement on adrenal incidentaloma

European Journal of Endocrinology · 2011 · Vol. 164(6) · pp. 851–870

Massimo Terzolo✉(Ospedale San Luigi Gonzaga)Antonio Stigliano(Sapienza University of Rome)Iacopo Chiodini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)Paola Loli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda)Lino Furlani(Ospedale Sacro Cuore Don Calabria)Giorgio Arnaldi(Marche Polytechnic University)Giuseppe Reimondo(Ospedale San Luigi Gonzaga)A. Pia(Ospedale San Luigi Gonzaga)Vincenzo Toscano(Sapienza University of Rome)Michele Zini(Endocrinology Research Center)Giorgio Borretta(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo)Enrico Papini(Ospedale Regina Apostolorum)Piernicola Garofalo(Hospital Universitário Onofre Lopes)Bruno Allolio(University of Würzburg)B. Dupas(Centre Hospitalier Universitaire de Nantes)Franco Mantero(University of Padua)Antoine Tabarin(Université de Bordeaux)

View via DOI Publisher page

Abstract

Surgery is recommended for masses with suspicious radiological aspects and masses causing overt catecholamine or steroid excess. Data are insufficient to make firm recommendations for or against surgery in patients with SCS. However, adrenalectomy may be considered when an adequate medical therapy does not reach the treatment goals of associated diseases potentially linked to hypercortisolism.

Adrenal and Paraganglionic Tumors Hormonal Regulation and Hypertension Pituitary Gland Disorders and TreatmentsMedicineIncidentalomaSubclinical infectionNormetanephrineDexamethasone suppression testPheochromocytomaPrimary aldosteronismHyperaldosteronismAdrenalectomyAdenoma